Cargando…
Human heart-type fatty acid-binding protein as an early diagnostic marker of doxorubicin cardiac toxicity
Progressive cardiotoxicity following treatment with doxorubicin-based chemotherapy in patients with non-Hodgkin's lymphoma (NHL) may lead to late onset cardiomyopathy. So, early prediction of toxicity can lead to prevention of heart failure in these patients. The aim of this work was to investi...
Autores principales: | ElGhandour, Ashraf H., Sorady, Manal El, Azab, Sahar, ElRahman, Mohammed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222245/ http://dx.doi.org/10.4081/hr.2009.e6 |
Ejemplares similares
-
Assessment of fibroblast growth factor 19 as a non-invasive serum marker for hepatocellular carcinoma
por: Mohamed, Ghada Abdelrahman, et al.
Publicado: (2022) -
Association of serum zinc level and clinical outcome in Egyptian COVID-19 patients
por: Mansour, Ahmed M. F., et al.
Publicado: (2022) -
Heart-type fatty acid-binding protein as a predictor of cardiac ischemia in intractable seizures in children
por: El Shorbagy, Hatem H., et al.
Publicado: (2016) -
Mac-2 binding protein in non-alcoholic fatty liver disease: Is it a reliable diagnostic biomarker? A pilot study
por: El-Aziz, Rokaya Abd, et al.
Publicado: (2020) -
Glycine protects against doxorubicin-induced heart toxicity in mice
por: Shosha, Mayada I., et al.
Publicado: (2023)